In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 2983-2989

  Sigurdardottir, Thorgerdur ^a   Andersson, Pia ^a   Davoudi, Mina ^a   Malmsten, Martin ^b   Schmidtchen, Artur ^a   Bodelsson, Mikael ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CATHELICICIN LL 37; CATHELICIDIN; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN FKR; PROTEIN GKE; PROTEIN LLG; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; COMPUTER MODEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; GRANULOCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PSEUDOMONAS AERUGINOSA; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CHEMOTAXIS, LEUKOCYTE; DNA FRAGMENTATION; GRANULOCYTES; HUMANS; LIPOPOLYSACCHARIDES; LIPOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NITRATES; NITRITES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SEPSIS;

EID: 33748715012     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01583-05     Document Type: Article

References (32)

1. Agerberth, B., H. Gunne, J. Odeberg, P. Kogner, H. G. Boman, and G. H. Gudmundsson. 1995. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92:195-199.
2. Boman, H. G. 2003. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254:197-215.
3. Bowdish, D. M., D. J. Davidson, Y. E. Lau, K. Lee, M. G. Scott, and R. E. Hancock. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77:451-459.
4. Ciornei, C. D., A. Egesten, and M. Bodelsson. 2003. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol. Scand. 47:213-220.
5. Ciornei, C. D., A. Egesten, M. Engström, K. Törnebrandt, and M. Bodelsson. 2002. Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis. Acta Anaesthesiol. Scand. 46:1111-1118.
6. Ciornei, C. D., T. Sigurdardottir, A. Schmidtchen, and M. Bodelsson. 2005. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob. Agents Chemother. 49:2845-2850.
7. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885-891.
8. Cowland, J. B., A. H. Johnsen, and N. Borregaard. 1995. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368:173-176.
9. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069-1074.
10. Fukumoto, K., I. Nagaoka, A. Yamataka, H. Kobayashi, T. Yanai, Y. Kato, and T. Miyano. 2005. Effect of antibacterial cathelicidin peptide CAP18/ LL-37 on sepsis in neonatal rats. Pediatr. Surg. Int. 21:20-24.
11. Greenfield, N., and G. D. Fasman. 1969. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108-4116.
12. Hotchkiss. R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-150.
13. Jackson, J. J., and H. Kropp. 1992. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 165:1033-1041.
14. Johansson, J., G. H. Gudmundsson, M. E. Rottenberg, K. D. Berndt, and B. Agerberth. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273:3718-3724.
15. Kapp, G. T., J. S. Richardson, and T. G. Oas. 2004. Kinetic role of helix caps in protein folding is context-dependent. Biochemistry 43:3814-3823.
16. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
17. Lacroix, E., A. R. Viguera, and L. Serrano. 1998. Elucidating the folding problem of alpha-helices: local motifs, long-range electrostatics, ionic-strength dependence and prediction of NMR parameters. J. Mol. Biol. 284:173-191.
18. Larrick, J. W., M. Hirata, R. F. Balint, J. Lee, J. Zhong, and S. C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
19. Lehrer, R. I., M. Rosenman, S. S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
20. Murakami, M., B. Lopez-Garcia, M. Braff, R. A. Dorschner, and R. L. Gallo. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172:3070-3077.
21. Opal, S. M., and C. E. Huber. 2002. Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit. Care 6:125-136.
22. Richardson, J. S., and D. C. Richardson. 1988. Amino acid preferences for specific locations at the ends of alpha helices. Science 240:1648-1652.
23. Schmidtchen, A., I. M. Frick, E. Andersson, H. Tapper, and L. Björck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
24. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aurens-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
25. Sjögren, H., and S. Ulvenlund. 2005. Comparison of the helix-coil transition of a titrating polypeptide in aqueous solutions and at the air-water interface. Biophys. Chem. 116:11-21.
26. Sørensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959.
27. Sørensen, O. E., L. Gram, A. H. Johnsen, E. Andersson, S. Bangsbøll, G. S. Tjabringa, P. S. Hiemstra, J. Malm, A. Egesten, and N. Borregaard. 2003. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J. Biol. Chem. 278:28540-28546.
28. Toh, C. H., and M. Dennis. 2003. Disseminated intravascular coagulation: old disease, new hope. Br. Med. J. 327:974-977.
29. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
30. Turner, J., Y. Cho, N. N. Dinh, A. J. Waring, and R. I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42:2206-2214.
31. Wang, Y., B. Agerberth, A. Löthgren, A. Almstedt, and J. Johansson. 1998. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273:33115-33118.
32. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.